| Name | Title | Contact Details |
|---|
Integra ServiceConnect is a non-clinical healthcare service company that connects people to service that improves their health. Specializing in community-based non-clinical support for individuals with healthcare and related social service needs, the Owings Mills, Md.-based company helps health plans, health systems and government organizations find, engage and connect underserved members to care that can preserve and improve their health. Integra has been providing community-based services for individuals with complex healthcare needs for more than two decades.
We believe that whole food based nutrition containing collagen is essential for one`s overall health, beauty, fitness and well-being. Our ancestors utilized sustainable whole animal nutrition, which provided an abundant amount of collagen. Over the past century modern food processing has removed this natural and healthy protein from our diets. Collagen is vital for our body and is the basic building block of skin, hair, nails, bones and joints. We promote optimal health, beauty, vibrant youth, and overall wellness with our products. We are dedicated to providing 100% natural, whole food proteins that support animal well-being and sustainable eco-friendly practices. Our happy cows openly graze on lush natural grass pastures providing the highest quality of protein.
WPC Central (Womens Pregnancy Center) is a Tucson, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Exemplar Pharmaceuticals is a Fall River, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
BioAtla was founded in 2007 and employs deep expertise in protein engineering to develop better monoclonal antibody and other protein therapeutics. Our suite of proprietary technologies (protected by more than 70 issued patents and patent applications) has enabled us to develop dozens of novel therapeutic proteins for our partners and our own pipeline. We accelerate the process from target discovery to manufacturing and preclinical studies by creating drugs with more selective targeting, greater affinity, and more cost-efficient and predictable manufacturing. In the process we also create valuable, protectable IP that gives our partners significant competitive advantage. The culmination of our protein evolution technologies is our Conditionally Active Biologics (CAB)platform. Monoclonal antibodies or enzymes can be engineered for selective conditional activation, i.e. the protein`s functions are designed to modulate with changes in microphysical conditions (e.g., pH level, oxidation, temperature, pressure concentration, presence of certain ions, hydrophobicity and competing protein binding). Tumors and other kinds of diseased tissue give rise to unique localized conditions distinct from normal tissue. CAB designed monoclonal antibodies can be programmed to deliver an ADC payload and/or recruit the immune response to specific sites and conditions in the body.